EPISODE · Aug 8, 2016 · 5 MIN
GSK and Alphabet team up to find biolectronic cures
from FT News in Focus
Google’s parent company Alphabet is teaming up with British drug company GlaxoSmithKline to invest in bioelectronics. The aim is to treat diseases by targeting the electronic signals that pass along the body’s nerves. Chris Nuttall discusses the prospects for this new branch of medicine with the FT’s Science editor Clive Cookson Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
GSK and Alphabet team up to find biolectronic cures
0:00
5:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of FT News in Focus?
This episode is 5 minutes long.
When was this FT News in Focus episode published?
This episode was published on August 8, 2016.
Can I download this FT News in Focus episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!